Principal
- Marco.Boorsma@forbion.com
- Download vCard 
Marco is Principal at Forbion and joined the team in 2007 as Analyst.
Before joining Forbion Marco was Business Development Director at DSM Pharmaceutical Products, responsible for out-licensing of biomanufacturing technology and securing and managing contract manufacturing projects. Prior to that Marco was project manager and scientist responsible for process development and cGMP manufacturing of biopharmaceuticals. While at Cytos Biotechnology (Switzerland)Marco developed several cell lines and processes for high-value biosimilar proteins.
At Forbion Marco is responsible for the investment process from scouting and analyzing new opportunities to the investment itself. He also provides market and trend analyses supporting Forbion’s business strategy.
Marco is Observer to the Board of Cardoz AB and Exosome Diagnostics.
After obtaining a master’s degree in molecular biology from the University of Groningen, Marco received his PhD in biotechnology from the ETH Institute for Technology in Zürich, Switzerland for his work on virus-based gene expression systems. Marco executed his work in the groups of Prof. James Bailey and Prof. Ari Helenius at the ETH, and at the Laboratory of Molecular Biology of the Medical Research Counsel in Cambridge, UK.
